NASDAQ:FUSN
Fusion Pharmaceuticals Inc.
- Stock
locale
Canadamarket
STOCKSindustry
Biotechnologywebsite
fusionpharma.comipo date
Jun 26, 2020
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order to selectively deliver the alpha ...Show More
Earnings
Earnings Release in 10 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus